Skip to main content
Clinical Trials/NCT03323086
NCT03323086CompletedNot Applicable

Reducing Alcohol-related HIV/STI Risk for Women in Reproductive Health Clinics

The Miriam Hospital1 site in 1 country50 target enrollmentStarted: October 18, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Feasibility of Providing Intervention

Study Overview

Brief Summary

This study will investigate whether BI and technology extenders are feasible and acceptable for female patients at a reproductive health center (ages 18-29).

Detailed Description

This study will assess the feasibility and acceptability, and obtain initial evidence of the efficacy, of the BI and technology extenders. At-risk women drinkers (N = 50) recruited from a reproductive health care clinic will be assessed, randomly assigned to the integrated BI or control (a Centers for Disease Control and Prevention-produced brochure with information about alcohol and women's health), and reassessed at 3 months to determine impact on alcohol use, condom use, and number of partners as well as hypothesized mediators.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 29 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18-29 years
  • •Meeting NIAAA definition of "at-risk" drinking (>3 drinks on any day in the last 3 months18 and/or >7 drinks per week)
  • •Sexual risk behavior (i.e., last 3 months: vaginal/anal intercourse with >1 partner; vaginal/anal intercourse with a partner who has other partners; inconsistent condom use; new relationship (under 3 months))
  • •English speaking
  • •Absence of acute intoxication, depression, or suicidal ideation
  • •No plans for relocation

Exclusion Criteria

  • •Under 18 years old or older than 29 years old
  • •Non-English speaking
  • •Suicidal Ideation
  • •Relocating
  • •Clinic provider advising against recruitment in the study
  • •Unwilling or unable to provide consent

Arms & Interventions

Brief Intervention (BI) with Technology Extender

Experimental

Participants assigned to BI condition will receive a face to face session lasting 45-60 minutes delivered by a health coach. Following the session, participants will be given access to a study website and receive texts-of-the day on study topics.

Intervention: Brief Intervention (BI) with Technology Extender (Behavioral)

Brochure

Other

Participants assigned to the Brochure condition will receive materials prepared by the Centers for Disease Control and Prevention on the study topics.

Intervention: Brochure (Other)

Outcomes

Primary Outcomes

Feasibility of Providing Intervention

Time Frame: Immediately following intervention session (post-intervention), up to 30 minutes

percentage of individuals who attended their intervention

Secondary Outcomes

  • Session Evaluation Questionnaire(Immediately following intervention session (post-intervention), up to 30 minutes)
  • Number of Sexual Partners(3-month Follow-up)
  • Condomless Sex(3-month Follow-up)
  • Alcohol Use Quantity(3-month Follow-up)
  • Alcohol Use Binge Frequency(3-month Follow-up)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael P. Carey

Professor and Director, Centers for Behavioral and Preventive Medicine, The Miriam Hospital

The Miriam Hospital

Study Sites (1)

Loading locations...

Similar Trials